# NON-DISCLOSURE AGREEMENT (NDA)
## FOR CAREMATCH AI BUSINESS & TECHNOLOGY

---

**MUTUAL NON-DISCLOSURE AND NON-COMPETE AGREEMENT**

This Non-Disclosure Agreement (the "**Agreement**") is entered into as of ________________ (the "**Effective Date**"), by and between:

**DISCLOSING PARTY:**
- **Company Name:** CareMatch AI Limited
- **Address:** ________________________________________
- **Contact Person:** ________________________________________
- **Email:** ________________________________________

(Hereinafter referred to as "**Company**" or "**Disclosing Party**")

AND

**RECEIVING PARTY:**
- **Full Name:** ________________________________________
- **Address:** ________________________________________
- **Email:** ________________________________________
- **Phone Number:** ________________________________________
- **Position/Role:** ☐ Developer/Engineer ☐ Designer ☐ Product Manager ☐ Other: ______________

(Hereinafter referred to as "**Recipient**" or "**Receiving Party**")

Collectively referred to as the "**Parties**" and individually as a "**Party**."

---

## RECITALS

**WHEREAS**, the Company has developed and is developing proprietary healthcare technology, software applications, business strategies, and intellectual property relating to an AI-powered healthcare ecosystem known as "**CareMatch AI**";

**WHEREAS**, the Company is engaged in the recruitment and evaluation of candidates, contractors, consultants, and potential employees for various technical and business roles;

**WHEREAS**, in the course of recruitment, interviews, technical assessments, and/or employment discussions, the Company may disclose to the Recipient certain confidential, proprietary, and trade secret information;

**WHEREAS**, the Recipient acknowledges that such information is highly valuable, competitively sensitive, and essential to the Company's business success;

**WHEREAS**, the Parties wish to protect the confidentiality of such information and prevent unauthorized use, disclosure, or implementation;

**NOW, THEREFORE**, in consideration of the mutual covenants and promises contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

---

## 1. DEFINITIONS

For purposes of this Agreement, the following terms shall have the meanings set forth below:

### 1.1 **"Confidential Information"**
Means any and all information, whether written, oral, electronic, visual, or otherwise, disclosed by the Company to the Recipient, including but not limited to:

**A. Technical Information:**
- Source code, object code, software architecture, algorithms, and APIs
- AI models, machine learning algorithms, training data, and datasets
- Database schemas, structures, and content (including NAFDAC pharmaceutical database)
- System designs, technical specifications, and documentation
- Software features, functionalities, user interfaces, and user experiences
- Integration methods, offline-first technology architecture
- Cloud infrastructure configurations and deployment strategies
- Mobile application code (CareWebb, CareMatch Mobile, Clinic Bridge, Hospital Management Platform)
- AI orchestration flows, multi-model integration strategies
- Security protocols, encryption methods, and authentication systems

**B. Business Information:**
- Business plans, strategies, financial projections, and revenue models
- Marketing plans, go-to-market strategies, and customer acquisition methods
- Partnership agreements, contracts, and negotiation strategies
- Customer lists, user data, patient information, and healthcare provider networks
- Pricing strategies, subscription models, and monetization approaches
- Competitive analysis, market research, and industry insights
- Product roadmaps, feature development plans, and timelines
- Expansion plans (geographic, market, and product)
- Funding strategies, investor pitch materials, and valuations

**C. Operational Information:**
- Internal processes, standard operating procedures, and workflows
- Organizational structure, team composition, and hiring plans
- Vendor relationships, supplier agreements, and service provider contracts
- Compliance frameworks, regulatory strategies (NDPR, NAFDAC, NHIA)
- Clinical governance protocols and medical safety procedures
- Quality assurance processes and testing methodologies

**D. Intellectual Property:**
- Inventions, discoveries, concepts, and ideas (whether patentable or not)
- Trade secrets, know-how, and proprietary methods
- Copyrighted materials, trademarks, brand assets, and creative works
- Domain names, social media accounts, and digital assets
- Research and development projects and clinical studies

**E. Healthcare-Specific Information:**
- Patient data management systems and health record architectures
- Clinical decision support algorithms and diagnostic tools
- Drug verification systems and NAFDAC integration methods
- Telemedicine protocols and mental health AI frameworks
- Hospital workflow optimization strategies
- Health analytics and reporting systems

### 1.2 **"Purpose"**
Means the evaluation of the Recipient for potential employment, engagement as a contractor/consultant, participation in technical assessments, interviews, or other business discussions related to CareMatch AI.

### 1.3 **"Competing Business"**
Means any business, venture, product, or service that:
- Provides AI-powered health assistance, symptom checking, or medical guidance
- Operates a healthcare provider navigation or directory platform
- Offers digital health records, personal health management systems
- Provides drug verification, pharmaceutical database services, or medication management
- Develops clinic management software or hospital management platforms
- Operates telemedicine, mental health support, or AI health coaching services
- Targets the African healthcare market or similar emerging markets
- Competes with CareMatch AI's products, services, or business model in any material way

---

## 2. CONFIDENTIALITY OBLIGATIONS

### 2.1 **Non-Disclosure**
The Recipient agrees to:
- (a) Hold all Confidential Information in strict confidence;
- (b) Not disclose, publish, disseminate, or communicate any Confidential Information to any third party without the prior written consent of the Company;
- (c) Not use Confidential Information for any purpose other than the Purpose;
- (d) Protect Confidential Information with the same degree of care used to protect their own confidential information, but in no event less than reasonable care;
- (e) Limit access to Confidential Information to only those individuals who have a legitimate need to know for the Purpose and who have been informed of the confidential nature of such information.

### 2.2 **Non-Use**
The Recipient shall not:
- (a) Use any Confidential Information to develop, create, or assist in developing any competing product, service, or technology;
- (b) Use any Confidential Information to benefit themselves or any third party;
- (c) Reverse engineer, decompile, disassemble, or otherwise attempt to derive the source code or underlying ideas of any software or technology disclosed;
- (d) Replicate, copy, or reproduce any Confidential Information except as strictly necessary for the Purpose;
- (e) File any patent application, copyright registration, or other intellectual property protection based on Confidential Information.

### 2.3 **Standard of Care**
The Recipient acknowledges that the Confidential Information is of critical commercial value and agrees to exercise the highest degree of care in safeguarding it.

---

## 3. EXCLUSIONS FROM CONFIDENTIAL INFORMATION

Confidential Information shall not include information that:

### 3.1 **Public Domain**
Is or becomes publicly available through no breach of this Agreement by the Recipient;

### 3.2 **Prior Knowledge**
Was in the Recipient's lawful possession prior to disclosure by the Company, as evidenced by written records;

### 3.3 **Independent Development**
Is independently developed by the Recipient without reference to or use of the Confidential Information, as evidenced by written records;

### 3.4 **Third-Party Disclosure**
Is lawfully obtained from a third party who has the right to disclose it without breach of any confidentiality obligation;

### 3.5 **Legal Requirement**
Is required to be disclosed by law, court order, or governmental regulation, provided that the Recipient:
- (a) Provides prompt written notice to the Company of such requirement;
- (b) Cooperates with the Company in seeking a protective order or other appropriate remedy;
- (c) Discloses only the minimum information required by law.

**NOTE:** The burden of proving any exclusion rests solely with the Recipient.

---

## 4. NON-COMPETE AND NON-SOLICITATION

### 4.1 **Non-Compete Covenant**
During the term of this Agreement and for a period of **TWO (2) YEARS** following the termination of this Agreement or cessation of discussions between the Parties (whichever is later), the Recipient agrees NOT to:

- (a) **Directly or indirectly** engage in, participate in, be employed by, consult for, provide services to, or have any financial interest in any Competing Business;
- (b) Develop, create, launch, or assist in the development of any product, service, platform, or technology that competes with CareMatch AI;
- (c) Use knowledge of CareMatch AI's business model, technology, or strategies to create a competing venture;
- (d) Invest in, advise, or support (financially or otherwise) any entity engaged in a Competing Business.

**Geographic Scope:** This restriction applies globally, with particular emphasis on Nigeria, West Africa, and any markets where CareMatch AI operates or has disclosed expansion plans.

### 4.2 **Non-Solicitation of Employees**
During the term of this Agreement and for **TWO (2) YEARS** thereafter, the Recipient agrees NOT to:
- (a) Solicit, recruit, hire, or attempt to hire any current or former employee, contractor, or consultant of the Company;
- (b) Encourage any employee or contractor to terminate their relationship with the Company;
- (c) Interfere with the Company's relationship with its employees, contractors, or consultants.

### 4.3 **Non-Solicitation of Business Relationships**
During the term of this Agreement and for **TWO (2) YEARS** thereafter, the Recipient agrees NOT to:
- (a) Solicit, divert, or attempt to divert any customer, client, hospital, clinic, healthcare provider, or business partner of the Company;
- (b) Interfere with any business relationship between the Company and its customers, partners, suppliers, or investors;
- (c) Use knowledge of the Company's business relationships for competitive purposes.

### 4.4 **Reasonableness**
The Recipient acknowledges that:
- The restrictions in this Section 4 are reasonable in scope, duration, and geographic area;
- They are necessary to protect the Company's legitimate business interests;
- The Recipient has had adequate opportunity to review and negotiate these terms;
- They will not prevent the Recipient from earning a livelihood in their field of expertise outside of Competing Businesses.

---

## 5. OWNERSHIP AND RETURN OF MATERIALS

### 5.1 **No Rights Granted**
This Agreement does not grant the Recipient any license, right, title, or interest in any Confidential Information, intellectual property, or proprietary materials of the Company. All Confidential Information remains the sole and exclusive property of the Company.

### 5.2 **Return or Destruction**
Upon the Company's written request or upon termination of this Agreement, the Recipient shall:
- (a) Immediately return to the Company all documents, materials, files, prototypes, devices, or other tangible items containing or relating to Confidential Information;
- (b) Permanently delete or destroy all electronic copies of Confidential Information from computers, mobile devices, cloud storage, email accounts, and any other storage media;
- (c) Provide written certification to the Company confirming compliance with this section within **FIVE (5) BUSINESS DAYS**.

### 5.3 **No Retention**
The Recipient shall not retain any copies, excerpts, or reproductions of Confidential Information in any form, except as required by law with prior written notice to the Company.

---

## 6. INTELLECTUAL PROPERTY ASSIGNMENT

### 6.1 **Work Product**
If the Recipient creates, develops, conceives, or contributes to any inventions, discoveries, improvements, works of authorship, software code, designs, or other intellectual property ("**Work Product**") that:
- (a) Results from exposure to Confidential Information;
- (b) Relates to the Company's business, products, or services;
- (c) Is created during the period of this Agreement;

Then such Work Product shall be deemed "**work made for hire**" and shall be the sole and exclusive property of the Company.

### 6.2 **Assignment**
To the extent any Work Product is not deemed "work made for hire," the Recipient hereby irrevocably assigns, transfers, and conveys to the Company all right, title, and interest in and to such Work Product, including all intellectual property rights therein.

### 6.3 **Further Assurances**
The Recipient agrees to execute any documents and take any actions reasonably requested by the Company to perfect the Company's ownership rights in any Work Product.

---

## 7. NO OBLIGATION TO HIRE OR CONTRACT

### 7.1 **Discretion**
The Recipient acknowledges and agrees that:
- (a) This Agreement does not create any obligation on the part of the Company to hire, engage, or contract with the Recipient;
- (b) The Company retains sole discretion regarding all employment and contracting decisions;
- (c) Disclosure of Confidential Information does not constitute an offer of employment or engagement.

### 7.2 **At-Will Employment**
If the Recipient is subsequently hired or engaged by the Company, such relationship shall be "at-will" (unless otherwise specified in a separate written agreement) and may be terminated by either Party at any time, with or without cause or notice, subject to applicable law.

---

## 8. TERM AND TERMINATION

### 8.1 **Term**
This Agreement shall commence on the Effective Date and shall continue until terminated by either Party upon **THIRTY (30) DAYS** written notice to the other Party.

### 8.2 **Survival**
The obligations of confidentiality, non-use, non-compete, non-solicitation, and intellectual property assignment shall survive termination of this Agreement and continue for the periods specified herein, but in no event less than **FIVE (5) YEARS** from the Effective Date.

### 8.3 **Perpetual Obligations**
Notwithstanding the above, the Recipient's obligations regarding trade secrets shall continue for as long as such information remains a trade secret under applicable law.

---

## 9. REMEDIES AND ENFORCEMENT

### 9.1 **Irreparable Harm**
The Recipient acknowledges and agrees that:
- (a) Any breach of this Agreement will cause irreparable harm and injury to the Company;
- (b) Monetary damages alone would be an inadequate remedy for such breach;
- (c) The Company shall be entitled to seek equitable relief, including injunctive relief and specific performance, without the necessity of proving actual damages or posting a bond.

### 9.2 **Cumulative Remedies**
The remedies provided in this Agreement are cumulative and in addition to any other remedies available at law or in equity.

### 9.3 **Liquidated Damages**
In addition to injunctive relief, in the event of a material breach of this Agreement by the Recipient, the Recipient shall pay the Company liquidated damages in the amount of:
- **₦50,000,000 (Fifty Million Naira) or $100,000 USD (whichever is greater)**

The Parties agree that this amount is a reasonable estimate of the actual damages the Company would suffer and is not a penalty.

### 9.4 **Attorney's Fees**
In any action to enforce this Agreement, the prevailing Party shall be entitled to recover its reasonable attorney's fees, costs, and expenses from the non-prevailing Party.

---

## 10. GENERAL PROVISIONS

### 10.1 **Governing Law**
This Agreement shall be governed by and construed in accordance with the laws of the **Federal Republic of Nigeria**, without regard to its conflict of law principles.

### 10.2 **Jurisdiction and Venue**
The Parties hereby submit to the exclusive jurisdiction of the courts located in **Lagos State, Nigeria** for any disputes arising out of or relating to this Agreement. Each Party irrevocably waives any objection to such venue.

### 10.3 **Entire Agreement**
This Agreement constitutes the entire agreement between the Parties concerning the subject matter hereof and supersedes all prior or contemporaneous oral or written agreements, understandings, or representations.

### 10.4 **Amendments**
No amendment, modification, or waiver of any provision of this Agreement shall be effective unless in writing and signed by both Parties.

### 10.5 **Severability**
If any provision of this Agreement is held to be invalid, illegal, or unenforceable, the remaining provisions shall continue in full force and effect. The invalid provision shall be modified to the minimum extent necessary to make it valid and enforceable.

### 10.6 **Waiver**
The failure of either Party to enforce any provision of this Agreement shall not be construed as a waiver of such provision or the right to enforce it in the future.

### 10.7 **Assignment**
The Recipient may not assign, transfer, or delegate any rights or obligations under this Agreement without the prior written consent of the Company. The Company may freely assign this Agreement. This Agreement shall be binding upon and inure to the benefit of the Parties and their respective successors and permitted assigns.

### 10.8 **Notices**
All notices required or permitted under this Agreement shall be in writing and delivered by:
- (a) Personal delivery;
- (b) Certified or registered mail, return receipt requested;
- (c) Reputable overnight courier service;
- (d) Email with confirmation of receipt.

Notices shall be sent to the addresses set forth above or to such other address as a Party may designate in writing.

### 10.9 **Counterparts and Electronic Signatures**
This Agreement may be executed in counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same instrument. Electronic signatures shall have the same force and effect as original signatures.

### 10.10 **Independent Legal Advice**
The Recipient acknowledges that:
- (a) They have been advised to seek independent legal counsel before signing this Agreement;
- (b) They have had adequate opportunity to review and understand the terms;
- (c) They are entering into this Agreement voluntarily and with full knowledge of its consequences.

### 10.11 **Language**
This Agreement is executed in the English language. If translated into any other language, the English version shall control in the event of any conflict or ambiguity.

---

## 11. ACKNOWLEDGMENTS AND REPRESENTATIONS

The Recipient acknowledges, represents, and warrants that:

1. They have carefully read and fully understand all terms and conditions of this Agreement;
2. They have had the opportunity to consult with legal counsel of their choosing;
3. They are entering into this Agreement freely and voluntarily, without duress or coercion;
4. The restrictions contained herein are reasonable and necessary to protect the Company's legitimate business interests;
5. They have the full power and authority to enter into this Agreement;
6. This Agreement does not conflict with any other agreement or obligation they may have;
7. They understand that violation of this Agreement may result in severe legal and financial consequences;
8. They acknowledge the highly competitive and sensitive nature of the healthcare technology industry;
9. They understand that the Company is relying on this Agreement in deciding whether to disclose Confidential Information;
10. They agree to be bound by all terms and conditions set forth herein.

---

## 12. SPECIAL PROVISIONS FOR HEALTHCARE TECHNOLOGY

### 12.1 **Patient Data and Privacy**
The Recipient acknowledges that CareMatch AI handles sensitive patient health information and agrees to:
- (a) Comply with all applicable data protection laws, including the Nigeria Data Protection Regulation (NDPR);
- (b) Not access, use, or disclose any patient data or personal health information without explicit authorization;
- (c) Maintain strict confidentiality of all health-related data and information;
- (d) Report any suspected data breach or security incident immediately to the Company.

### 12.2 **Regulatory Compliance**
The Recipient agrees to comply with all applicable healthcare regulations, including but not limited to:
- NAFDAC (National Agency for Food and Drug Administration and Control) regulations
- NHIA (National Health Insurance Authority) requirements
- Medical device regulations (if applicable)
- Clinical governance standards
- Professional medical ethics and standards

### 12.3 **Public Health Responsibility**
The Recipient acknowledges that CareMatch AI's mission involves public health and safety, and agrees to:
- (a) Not take any action that could harm patients or compromise healthcare delivery;
- (b) Report any safety concerns or ethical issues to the Company immediately;
- (c) Act in accordance with the highest standards of professional integrity.

---

## SIGNATURES

**BY SIGNING BELOW, THE PARTIES ACKNOWLEDGE THAT THEY HAVE READ, UNDERSTOOD, AND AGREE TO BE BOUND BY ALL TERMS AND CONDITIONS OF THIS AGREEMENT.**

---

### DISCLOSING PARTY (COMPANY):

**CareMatch AI Limited**

Signature: _________________________________

Printed Name: _________________________________

Title: _________________________________

Date: _________________________________

---

### RECEIVING PARTY (RECIPIENT):

**Full Legal Name:** _________________________________

Signature: _________________________________

Date: _________________________________

**Witness Name:** _________________________________

Witness Signature: _________________________________

Date: _________________________________

---

## APPENDIX A: ACKNOWLEDGMENT OF CONFIDENTIAL MATERIALS RECEIVED

The Recipient acknowledges receipt of the following confidential materials:

☐ Recruitment Business Overview Document  
☐ Technical Documentation  
☐ Source Code or Software Access  
☐ Business Plans or Financial Projections  
☐ Product Roadmaps  
☐ Partnership Agreements  
☐ Other (please specify): _________________________________

Date Materials Received: _________________________________

Recipient Signature: _________________________________

---

## APPENDIX B: PERMITTED DISCLOSURES LOG

If the Recipient believes disclosure is required by law, they must complete this log and provide it to the Company BEFORE making any disclosure:

| Date | Nature of Disclosure | Legal Authority Requiring Disclosure | Information to be Disclosed | Recipient of Disclosure |
|------|---------------------|---------------------------------------|----------------------------|------------------------|
|      |                     |                                       |                            |                        |

---

## APPENDIX C: DESTRUCTION CERTIFICATE

**TO BE COMPLETED UPON RETURN OR DESTRUCTION OF CONFIDENTIAL MATERIALS**

I, _________________________________ (Recipient Name), certify that I have:

☐ Returned all physical materials containing Confidential Information to CareMatch AI Limited  
☐ Permanently deleted all electronic copies of Confidential Information from all devices  
☐ Deleted all emails, attachments, and communications containing Confidential Information  
☐ Removed all Confidential Information from cloud storage, backup systems, and external drives  
☐ Not retained any copies, excerpts, notes, or derivatives of Confidential Information  

I understand that making a false certification is a material breach of the NDA and may result in legal action.

Signature: _________________________________

Date: _________________________________

---

**END OF AGREEMENT**

*This document was prepared for CareMatch AI Limited. It is recommended that both parties seek independent legal counsel before execution. This template should be reviewed by a qualified attorney licensed in Nigeria to ensure compliance with current laws and regulations.*

**Document Version:** 1.0  
**Last Updated:** December 2025  
**Prepared For:** CareMatch AI Limited  
**Jurisdiction:** Federal Republic of Nigeria
